R. Rothlein

发表

RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation1

K. Herold, Yali Chen, A. Schmidt, 2008, The Journal of Immunology.

TTP4000, a soluble fusion protein inhibitor of Receptor for Advanced Glycation End Products (RAGE) is an effective therapy in animal models of Alzheimer's disease

M. Kindy, A. Mjalli, Bin Zhou, 2013 .

Controls T Cell Differentiation RAGE Ligation Affects T Cell Activation and

K. Herold, Yali Chen, A. Schmidt, 2008 .

New Class of Orthopoxvirus Antiviral Drugs That Block Viral Maturation

Dennis E. Hruby, Chelsea M. Byrd, A. Mjalli, 2004, Journal of Virology.

Stability of K-ras Mutations Throughout the Natural History of Human Colorectal Cancer

R. Rothlein, Springer Ta, Shiigi Sm, 1992 .

TTP889, a Novel Orally Active Partial Inhibitor of FIXa Inhibits Clotting in Two A/V Shunt Models without Prolonging Bleeding Times.

A. Schmidt, A. Mjalli, E. Rose, 2005 .

Effects of AgRP Inhibition on Energy Balance and Metabolism in Rodent Models

S. Wardlaw, C. Valcarce, R. Dutia, 2013, PloS one.

The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.

R. Nelson, B. Sahagan, A. Schmidt, 2009, Current opinion in investigational drugs.

Role of pulmonary phagocytes in host defense against group B streptococci in preterm versus term rabbit lung.

C. Smith, R. Rothlein, D. Anderson, 1992, The Journal of infectious diseases.

Neutrophil Accumulation in Ischemic Canine Myocardium: Insights Into Time Course, Distribution, and Mechanism of Localization During Early Reperfusion

W. Dreyer, M. Entman, C. Smith, 1991, Circulation.